Market Cap
US$11.0b
Last Updated
2021/03/03 00:32 UTC
Data Sources
Company Financials +
Executive Summary
Invesco Ltd. is a publicly owned investment manager. More Details
Rewards
Risk Analysis
Snowflake Analysis
Very undervalued with excellent balance sheet and pays a dividend.
Similar Companies
Share Price & News
How has Invesco's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IVZ is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: IVZ's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
6.1%
IVZ
1.0%
US Capital Markets
-0.7%
US Market
1 Year Return
67.6%
IVZ
38.8%
US Capital Markets
36.6%
US Market
Return vs Industry: IVZ exceeded the US Capital Markets industry which returned 38.8% over the past year.
Return vs Market: IVZ exceeded the US Market which returned 36.6% over the past year.
Shareholder returns
| IVZ | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.1% | 1.0% | -0.7% |
| 30 Day | 16.3% | 10.8% | 4.3% |
| 90 Day | 42.9% | 17.0% | 8.1% |
| 1 Year | 76.5%67.6% | 42.2%38.8% | 39.6%36.6% |
| 3 Year | -14.1%-27.7% | 40.1%29.7% | 53.5%43.7% |
| 5 Year | 8.4%-15.1% | 152.2%121.0% | 123.7%98.8% |
Long-Term Price Volatility Vs. Market
How volatile is Invesco's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
Does Invesco's (NYSE:IVZ) Share Price Gain of 56% Match Its Business Performance?3 weeks ago | Simply Wall St
We Wouldn't Be Too Quick To Buy Invesco Ltd. (NYSE:IVZ) Before It Goes Ex-Dividend1 month ago | Simply Wall St
Analysts Just Shipped A Substantial Upgrade To Their Invesco Ltd. (NYSE:IVZ) EstimatesValuation
Is Invesco undervalued compared to its fair value and its price relative to the market?
48.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IVZ ($23.95) is trading below our estimate of fair value ($46.66)
Significantly Below Fair Value: IVZ is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: IVZ is good value based on its PE Ratio (21x) compared to the US Capital Markets industry average (22.8x).
PE vs Market: IVZ is good value based on its PE Ratio (21x) compared to the US market (21.4x).
Price to Earnings Growth Ratio
PEG Ratio: IVZ is good value based on its PEG Ratio (0.7x)
Price to Book Ratio
PB vs Industry: IVZ is good value based on its PB Ratio (1.1x) compared to the US Capital Markets industry average (15x).
Next Steps
Future Growth
How is Invesco forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
31.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IVZ's forecast earnings growth (31.9% per year) is above the savings rate (2%).
Earnings vs Market: IVZ's earnings (31.9% per year) are forecast to grow faster than the US market (19.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IVZ's revenue is expected to decline over the next 3 years (-6.3% per year).
High Growth Revenue: IVZ's revenue is forecast to decline over the next 3 years (-6.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IVZ's Return on Equity is forecast to be low in 3 years time (9.2%).
Next Steps
Past Performance
How has Invesco performed over the past 5 years?
-12.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IVZ has a large one-off loss of $359.3M impacting its December 31 2020 financial results.
Growing Profit Margin: IVZ's current net profit margins (8.5%) are lower than last year (9.2%).
Past Earnings Growth Analysis
Earnings Trend: IVZ's earnings have declined by 12.4% per year over the past 5 years.
Accelerating Growth: IVZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IVZ had negative earnings growth (-6.9%) over the past year, making it difficult to compare to the Capital Markets industry average (10.4%).
Return on Equity
High ROE: IVZ's Return on Equity (5.4%) is considered low.
Next Steps
Financial Health
How is Invesco's financial position?
Financial Position Analysis
Short Term Liabilities: IVZ's short term assets ($18.4B) exceed its short term liabilities ($2.7B).
Long Term Liabilities: IVZ's short term assets ($18.4B) do not cover its long term liabilities ($18.8B).
Debt to Equity History and Analysis
Debt Level: IVZ's debt to equity ratio (13.9%) is considered satisfactory.
Reducing Debt: IVZ's debt to equity ratio has reduced from 23.4% to 13.9% over the past 5 years.
Debt Coverage: IVZ's debt is well covered by operating cash flow (59.1%).
Interest Coverage: IVZ's interest payments on its debt are well covered by EBIT (1316.2x coverage).
Balance Sheet
Next Steps
Dividend
What is Invesco current dividend yield, its reliability and sustainability?
2.59%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IVZ's dividend (2.59%) is higher than the bottom 25% of dividend payers in the US market (1.32%).
High Dividend: IVZ's dividend (2.59%) is low compared to the top 25% of dividend payers in the US market (3.72%).
Stability and Growth of Payments
Stable Dividend: IVZ's dividends per share have been stable in the past 10 years.
Growing Dividend: IVZ's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (54.3%), IVZ's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: IVZ's dividends in 3 years are forecast to be well covered by earnings (22.5% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.0yrs
Average management tenure
CEO
Marty Flanagan (60 yo)
15.58yrs
Tenure
US$11,518,949
Compensation
Mr. Martin L. Flanagan, CFA, CPA is the President, Chief Executive Officer and Director of Invesco Ltd. since August 1, 2005. Previously, Mr. Flanagan served as the Chief Executive Officer, Advisor to the ...
CEO Compensation Analysis
Compensation vs Market: Marty's total compensation ($USD11.52M) is about average for companies of similar size in the US market ($USD10.48M).
Compensation vs Earnings: Marty's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.58yrs | US$11.52m | 0.96% $ 105.6m | |
| Senior Managing Director of Investments | 4yrs | US$5.33m | 0.12% $ 12.9m | |
| Senior MD & Head of Invesco Asia Pacific | 20.08yrs | US$4.65m | 0.12% $ 13.7m | |
| Vice Chairman | 15.42yrs | US$3.43m | 0.14% $ 15.7m | |
| Senior MD & Head of the Americas | 5.17yrs | US$4.54m | 0.036% $ 4.0m | |
| Managing Partner & Head of Private Equity | 3.08yrs | no data | no data | |
| Senior MD & CFO | 0.58yr | no data | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Chief Accounting Officer | 4yrs | no data | 0.023% $ 2.5m | |
| MD, CTO & Global Head of Technology | no data | no data | no data | |
| Chief Investment Officer of Global Investment Grade and Emerging Markets | no data | no data | no data | |
| Senior MD & Chief Administrative Officer | 2.33yrs | no data | 0.016% $ 1.8m |
4.0yrs
Average Tenure
57yo
Average Age
Experienced Management: IVZ's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.58yrs | US$11.52m | 0.96% $ 105.6m | |
| Non Executive Director | 0.33yr | no data | 0.00024% $ 26.4k | |
| Independent Non-Executive Chairman | no data | US$373.74k | 0.013% $ 1.4m | |
| Independent Non-Executive Director | 9.17yrs | US$279.97k | 0.014% $ 1.5m | |
| Non Executive Director | 0.25yr | no data | 0.00013% $ 14.3k | |
| Independent Non-Executive Director | 1.83yrs | US$92.35k | 0.0038% $ 416.7k | |
| Independent Non-Executive Director | 11.17yrs | US$314.97k | 0.012% $ 1.3m | |
| Independent Non-Executive Director | 19yrs | US$264.97k | 0.014% $ 1.5m | |
| Independent Non-Executive Director | 3.83yrs | US$264.97k | 0.011% $ 1.2m | |
| Director | 0.33yr | no data | 0.00024% $ 26.4k | |
| Chairman of Invesco Leveraged High Yield Fund Limited | no data | no data | no data | |
| Independent Non-Executive Director | 5.83yrs | US$264.97k | 0.0083% $ 917.0k |
4.8yrs
Average Tenure
67yo
Average Age
Experienced Board: IVZ's board of directors are considered experienced (4.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Invesco Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Invesco Ltd.
- Ticker: IVZ
- Exchange: NYSE
- Founded: 1935
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Market Cap: US$10.995b
- Shares outstanding: 459.07m
- Website: https://www.invesco.com
Number of Employees
Location
- Invesco Ltd.
- Two Peachtree Pointe
- 1555 Peachtree Street, NE, Suite 1800
- Atlanta
- Georgia
- 30309
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 3IW | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Aug 1995 |
| 0UAN | LSE (London Stock Exchange) | Yes | Common Shares | GB | USD | Aug 1995 |
| IVZ | NYSE (New York Stock Exchange) | Yes | Common Shares | US | USD | Aug 1995 |
| I1VZ34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REPR 1 COM | BR | BRL | Dec 2019 |
Biography
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/03/03 00:32 |
| End of Day Share Price | 2021/03/02 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.